Edition:
United Kingdom

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

116.60EUR
15 Dec 2017
Change (% chg)

€0.50 (+0.43%)
Prev Close
€116.10
Open
€116.25
Day's High
€118.60
Day's Low
€114.85
Volume
29,779
Avg. Vol
12,114
52-wk High
€177.30
52-wk Low
€102.10

Select another date:

Wed, Nov 22 2017

BRIEF-Virbac postpones its option to buy Centrovet for three years

* REG-VIRBAC : AQUACULTURE: VIRBAC POSTPONES ITS OPTION TO BUY CENTROVET FOR THREE YEARS

BRIEF-Virbac Q3 sales fall to 192.7 million euros

* REG-VIRBAC: QUARTERLY SALES AFFECTED BY DISTRIBUTOR DESTOCKING IN THE UNITED STATES

Virbac cuts full-year revenue forecast amid still weak US sales

Sept 11 French veterinary pharmaceutical firm Virbac cut its full-year outlook on Monday, saying it now expected revenue to be little changed from last year after a fall in U.S. sales affected its first-half earnings.

BRIEF-Virbac H1 net profit group share rises to 13.9 ‍million euros

* H1 NET PROFIT GROUP SHARE EUR 13.9 ‍​MILLION VERSUS EUR 13.1 MILLION YEAR AGO

BRIEF-Creso Pharma signs commercialisation agreement with Virbac

* Signed a commercialisation agreement with Virbac, for the launch of its hemp‐based complementary animal feed products Source text for Eikon: Further company coverage:

BRIEF-Virbac Q‍2 consolidated revenue up to 234.8 million euros

* ‍CONSOLIDATED REVENUE IN Q2 AMOUNTED TO EUR 234.8 MILLION, UP SHARPLY BY +7.5% COMPARED TO SAME PERIOD IN 2016​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Virbac says Sébastien Huron to become new Chairman

* REG-VIRBAC : SÉBASTIEN HURON WILL BECOME THE NEW CHAIRMAN OF THE EXECUTIVE BOARD AS OF DECEMBER 2017

Select another date: